Where does MSD International GMBH rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), MSD International GMBH ranks #36,564 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does MSD International GMBH hold?

MSD International GMBH holds 7 US utility patents granted between 2017 and 2025, spanning 13 technology areas.

What is MSD International GMBH's Innovation Score?

MSD International GMBH has an Innovation Score of 50.8 out of 100 (top 12% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does MSD International GMBH focus on?

MSD International GMBH's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 4 patents, ranking #4,040 of 6,058 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is MSD International GMBH's patent grant rate increasing or decreasing?

MSD International GMBH's recent grant velocity is +400% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for MSD International GMBH's patents?

MSD International GMBH's patents average 18.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the MSD International GMBH patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

MSD International GMBH

USPTO PatentsView assignee record - 7 granted patents across 13 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, MSD ranks #36,564 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 13 technology areas.

#36,564
of 49,997 US assignees by volume: Top 12%
by Innovation Score (50.8/100): 18.1
avg claims per patent: +400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R36564 · Foreign Corporation #36,564 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #36,564/49,997
PHOTO-FINISH Morpheus
CPC-FOCUS A61P · 13 areas
INNOV-PAR 50.8/100
CLAIMS-RICH 18.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +400% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Morpheus AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How MSD’s 50.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (14%) Velocity 20.0 pts (39%) Breadth 12.7 pts (25%) Claim depth 10.9 pts (21%)

Qualcomm Incorporated · highest

85
MSD International · this assignee

51
3D Lighting… · lowest

7

What this shows MSD's Innovation Score is 50.8/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for MSD?

Each dot is one of MSD’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). MSD’s own 18.1 claims/patent is ABOVE the 13.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

MSD vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where MSD's grants concentrate

MSD International GMBH is a focused PatentsView assignee: 13 CPC subclasses with 57.1% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2023 (2 grants) versus a trough of 1 in 2017. By volume, MSD sits between Morpheus AG and Mucktape LLC.

MSD's three-year grant acceleration

MSD International GMBH shows 4 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Morpheus

7
Mosaic Biosciences

7
Moteck Electric

7
Mozido

7
MSN Laboratories…

7
Mtek-smart

7
MTS IP Holdings

7
Mucktape

7
MSD International ◀

7

What this shows MSD holds 7 patents at rank #36,424, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near MSD

By rank, the assignees closest to #36,424 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in MSD's primary technology class.

MSD's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

MSD International GMBH patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	14.3%
2021	1	14.3%
2023	2	28.6%
2024	2	28.6%
2025partial year	1	14.3%

Which technologies does MSD International GMBH patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

C07D - Heterocyclic Compounds 2

G06F - Electric Digital Data Processing 2

G06N - Computing Arrangements Based ON Specific Computational Models 2

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

C07K - Peptides 2

G06V - Image OR Video Recognition OR Understanding 1

G06T - Image Data Processing OR Generation, IN General 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 1

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

MSD International GMBH's patent record in context - here's where to go next.

MSD International GMBH's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 57.1% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #36,564 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare MSD International GMBH against Morpheus AG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 50.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.